Form 8-K - Current report:
SEC Accession No. 0001104659-24-032973
Filing Date
2024-03-11
Accepted
2024-03-11 16:10:45
Documents
14
Period of Report
2024-03-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm248437d1_8k.htm   iXBRL 8-K 30110
  Complete submission text file 0001104659-24-032973.txt   205892

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bcel-20240308.xsd EX-101.SCH 3009
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcel-20240308_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcel-20240308_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT tm248437d1_8k_htm.xml XML 3729
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

EIN.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38935 | Film No.: 24738086
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)